HCPCS Level II code V2631 denotes an iris supported intraocular lens, an ophthalmic implant used when standard capsular fixation is not feasible. This code matters nationally because it identifies a specialized device category with distinct surgical implications and payment considerations across public and commercial payers. Proper coding impacts device reimbursement, device reporting, and procedural billing clarity for surgeons and facilities.

Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the device and clinical context, an outline of typical sites of service, and the scope of common modifiers associated with device and procedural billing. The publication summarizes what providers and billing teams need to know about claims classification and administrative handling of this implant code.

This summary also highlights the topics addressed in the full publication: national benchmarks where available, payer coverage patterns, coding nuances related to device versus procedure reporting, and relevant policy or coverage update considerations. Data gaps in the input are identified where present. The focus is national in scope and intended for clinicians, coding professionals, and revenue cycle staff seeking clarity on billing and administrative treatment of an iris supported intraocular lens under HCPCS Level II code V2631.